Acadia Healthcare Data Scientist Salaries in Bowling Green, KY
The average Data Scientist at Acadia Healthcare in Bowling Green, KY earns an estimated $138,908 annually, comprising a $117,570 base salary and a $21,337 bonus. This compensation is higher than the US average for Data Scientists, with salaries ranging from $47,500 to $280,000. Data Scientists at Acadia Healthcare generally believe they are not compensated fairly and are dissatisfied with their benefits.
152,445 Shares in Acadia Healthcare Company, Inc. $ACHC Bought by Lisanti Capital Growth LLC
Lisanti Capital Growth LLC has acquired 152,445 shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) worth approximately $4.5 million, representing about 0.16% of the company. Despite Acadia Healthcare reporting better-than-expected quarterly EPS and revenue, its revenue declined year-over-year, and it posted a negative net margin. Analyst sentiment is mixed, with an overall "Hold" rating and an average price target of $29.85, although some firms have raised their price objectives.
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Average Recommendation of "Hold" from Analysts
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has received a "Hold" consensus rating from analysts, with an average 12-month price target of $29.85. The company recently reported quarterly EPS of $0.38, exceeding estimates, and revenues of $865.84 million, despite a slight year-over-year decline. Major institutional investors, including BlackRock and Goldman Sachs, have either established or expanded their positions in Acadia Healthcare.
U.S. Mental Health Treatment Market Report 2026–2030: Evaluating $159 Billion Forecast, Digital App Adoption, and Strategies of Acadia Healthcare, UHS, Talkspace, and Elevance Health
A new report by Marketdata LLC examines the U.S. mental health services market, forecasting its value to reach $159 billion by 2030. The study analyzes the impact of clinical facility expansion, payer integration, and the growth of digital therapy platforms from companies like Acadia Healthcare, UHS, Talkspace, and Elevance Health. It also addresses the industry's fragmentation, sustained demand, technology adoption, and ongoing challenges related to workforce shortages and accessibility.
Does Raised 2026 EBITDA Guidance And Expansion Strategy Change The Bull Case For Acadia Healthcare (ACHC)?
Acadia Healthcare (ACHC) recently increased its 2026 adjusted EBITDA guidance and is pursuing network expansion through joint ventures and new facilities, driven by demand for behavioral health services. While this indicates management confidence in earnings potential, the company still faces pressure from operating and legal costs. The article explores how this upgraded guidance impacts Acadia's investment outlook, emphasizing that unresolved legal and regulatory investigations remain a significant risk for investors despite the positive short-term outlook.
Does Raised 2026 EBITDA Guidance And Expansion Strategy Change The Bull Case For Acadia Healthcare (ACHC)?
Acadia Healthcare (ACHC) recently increased its 2026 adjusted EBITDA guidance and is expanding its network through joint ventures and new facilities, driven by demand for behavioral health services. While this indicates management confidence in growth, the company continues to face margin pressure and legal costs. Investors need to weigh the potential for sustained demand and expansion against ongoing operational and legal expenses to determine long-term profitability.
Does Raised 2026 EBITDA Guidance And Expansion Strategy Change The Bull Case For Acadia Healthcare (ACHC)?
Acadia Healthcare has increased its 2026 adjusted EBITDA guidance and is pursuing network expansion despite facing operating and legal costs. While this indicates management's growing confidence in its expansion strategy, concerns persist regarding eroding earnings quality due to unresolved legal and regulatory investigations. The article suggests that while the guidance uplift is positive, the impact on durable profitability and the risks associated with legal costs remain central to the investment narrative.
Should You Continue to Hold ACHC Stock at an 18.17X P/E Valuation?
Acadia Healthcare Company, Inc. (ACHC) benefits from strong demand for behavioral health services and is expanding its network. While the company shows solid growth and financial health, its stock trades at a premium compared to industry peers. ACHC carries a Zacks Rank #3 (Hold) due to its valuation and increasing operating expenses despite positive earnings surprises and raised EBITDA guidance.
UBS Adjusts Price Target on Acadia Healthcare to $1.50 From $4.50, Keeps Neutral Rating
UBS has adjusted its price target for Acadia Healthcare (referred to as Accendra Health in the article) to $1.50, down from $4.50, while maintaining a Neutral rating on the stock. This adjustment follows similar downgrades and price target reductions from other firms like Citigroup and Baird, indicating a broader shift in analyst sentiment. The company, which provides products and services for health beyond the hospital, recently updated its earnings guidance and reported Q2 2026 results.
Wellington Group (ACHC) discloses 6.15% beneficial stake in Acadia Healthcare
Wellington Management Group LLP and its related entities have disclosed a 6.15% beneficial ownership stake in Acadia Healthcare Company, Inc. (ACHC) through a Schedule 13G/A SEC filing. The ownership is held by investment advisory clients of various Wellington investment advisers, indicating shared voting and dispositive powers rather than sole control by Wellington. The filing details the specific shared voting and dispositive powers held by different Wellington entities over Acadia Healthcare shares.
Did Acadia Healthcare Company, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Halper Sadeh LLC is investigating whether certain officers and directors of Acadia Healthcare Company, Inc. (ACHC) breached their fiduciary duties to shareholders. The law firm is encouraging long-term shareholders to contact them to discuss legal rights and options, including seeking corporate governance reforms, return of funds, or other relief. Shareholder participation is highlighted as a way to improve company policies and enhance shareholder value.
Did Acadia Healthcare Company, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Halper Sadeh LLC, an investor rights law firm, is investigating whether officers and directors of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) breached their fiduciary duties to shareholders. The firm encourages long-term shareholders of Acadia stock to contact them to discuss potential legal rights and options, including seeking corporate governance reforms or financial incentives. Halper Sadeh LLC emphasizes that shareholder involvement can enhance transparency, accountability, and management, ultimately increasing shareholder value.
Royal Bank of Canada Purchases 274,785 Shares of Acadia Healthcare Company, Inc. $ACHC
Royal Bank of Canada significantly increased its stake in Acadia Healthcare Company, Inc. (ACHC) by 7,896.1% in the first quarter, acquiring an additional 274,785 shares. The fund now holds 278,265 shares valued at approximately $6.5 million. This increase makes Royal Bank of Canada a significant institutional investor in Acadia, which recently reported earnings exceeding analyst expectations despite a slight revenue decline.
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Acadia Healthcare
Faruqi & Faruqi, LLP is investigating potential securities claims against Acadia Healthcare Company, Inc. on behalf of investors who suffered losses exceeding $100,000 between February 28, 2020, and September 26, 2024. The investigation stems from allegations that Acadia Healthcare made false and misleading statements regarding its business practices, including holding patients against their will and deceiving insurance providers. Investors are encouraged to contact the firm by the December 16, 2024, lead plaintiff deadline.
Acadia Healthcare Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Acadia Healthcare Company, Inc. - ACHC
Kahn Swick & Foti, LLC (KSF) is continuing its investigation into Acadia Healthcare Company, Inc. (ACHC) regarding potential breaches of fiduciary duties by its officers and directors and violations of state or federal laws. This investigation follows disclosures by Acadia Healthcare concerning a federal inquiry into its practices and a lowered revenue outlook, leading to a securities class action lawsuit against the company. KSF is urging long-term shareholders or individuals with relevant information to contact the firm.
Acadia Healthcare (ACHC) Is Up 6.4% After Raising 2026 Revenue Outlook Despite Softer Q2 Earnings
Acadia Healthcare (ACHC) reported softer Q2 2026 earnings but saw its stock rise 6.4% after raising its full-year 2026 revenue guidance to US$3.40–US$3.45 billion. This indicates management's confidence in underlying demand, despite a decline in net income and EPS year-over-year. The article suggests that future growth hinges on increased volumes and pricing offsetting cost pressures, while also noting ongoing legal and regulatory risks.
Acadia Healthcare (ACHC) Is Up 6.4% After Raising 2026 Revenue Outlook Despite Softer Q2 Earnings
Acadia Healthcare (ACHC) reported softer Q2 2026 earnings but saw its stock rise 6.4% after management raised its full-year 2026 revenue guidance to US$3.40–US$3.45 billion. This optimism reflects confidence in demand and growth despite execution risks and cost pressures. The company's future hinges on whether higher volumes and pricing can overcome operational drags and weaker near-term profitability.
El Pasoan wins top award from Acadia Healthcare
Donna Juarez, an El Paso healthcare professional, has been awarded the prestigious Values in Action Peak Award by Acadia Healthcare. Juarez, who serves as the director of military veteran affairs for Rio Vista Behavioral Health, was selected from 500 nominees out of 29,000 employees. This award recognizes employees who demonstrate excellence, compassion, and service within the company.
A Look at Acadia Healthcare Co Inc (ACHC) After 4.7% Decline -- GF Value $41.52 vs Price $30.73
Acadia Healthcare Co Inc (ACHC) experienced a 4.7% decline, closing at $30.73, and is considered 26.0% undervalued according to GuruFocus' GF Value of $41.52. Despite an "Above Average" GF Score of 69/100, the company faces challenges with unprofitability and negative cash flow, warranting caution from investors. While gurus show positive sentiment by increasing stakes, the absence of insider transactions in recent months indicates potential near-term uncertainty.
Edgestream Partners L.P. Sells 42,454 Shares of Acadia Healthcare Company, Inc. $ACHC
Edgestream Partners L.P. significantly reduced its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by selling 42,454 shares in the first quarter, retaining 20,119 shares valued at $471,000. Despite this, Acadia Healthcare's stock opened up 1.8% at $32.24 and reported strong quarterly earnings of $0.38 EPS, exceeding estimates, though revenue was slightly down year-over-year. Analyst sentiment is mixed, with several firms raising price targets and maintaining Buy/Outperform ratings, yet the overall MarketBeat consensus is a "Hold" with a target price of $29.85.
FMR LLC discloses 5.5% Acadia Healthcare (ACHC) stake in amended ownership filing
FMR LLC has filed an amended Schedule 13G, disclosing a beneficial ownership of 5.5% in Acadia Healthcare Company, Inc. (ACHC), effective as of June 30, 2026. This translates to 5,015,726.57 shares, with FMR LLC exercising sole voting power over 5,011,333 shares and sole dispositive power over all beneficially owned shares. Abigail P. Johnson is also listed as a reporting person with sole dispositive power over the same number of shares.
Exclusive: Bradford Health Services Adds 2 Execs with UHS, Acadia Backgrounds
Bradford Health Services has appointed two new executives, Justin Adams as COO and John Hollinsworth to its Board of Directors, bringing 48 years of combined behavioral health experience from companies like UHS and Acadia. These appointments signify a shift in Bradford's growth strategy towards standardized practices, improved outcomes, and disciplined expansion rather than just acquisition-led growth. The company aims to refine programs using client data, leverage technology for care delivery, and meet evolving patient needs.
Acadia Healthcare Company Stock Short Interest Falls to 37.33%
This article reports on the significant decrease in short interest for Acadia Healthcare Company (ACHC) stock, which fell by 37.33% in the second half of July. Despite this reduction, a substantial percentage of the company's shares are still held short, indicating continued investor sentiment regarding its future performance. The article also provides details on the company's financial metrics and analyst ratings.
121,500 Shares in Acadia Healthcare Company, Inc. $ACHC Acquired by Militia Capital Management LLC
Militia Capital Management LLC acquired 121,500 shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) valued at approximately $2.84 million in the first quarter, representing about 0.13% of the company. Other institutional investors also adjusted their holdings in ACHC, which reported quarterly EPS of $0.38 against an $0.35 consensus, and revenue of $865.84 million, beating expectations despite a slight year-over-year decline. Analyst sentiment for Acadia Healthcare is mixed, with an overall "Hold" rating and an average price target of $29.85.
Sei Investments Co. Raises Stake in Acadia Healthcare Company, Inc. $ACHC
Sei Investments Co. increased its stake in Acadia Healthcare Company, Inc. by 39% in the first quarter, now holding 316,398 shares valued at $7.4 million. Despite mixed analyst ratings, the company beat its quarterly earnings and revenue expectations, reporting $0.38 EPS and $865.84 million in revenue. Other institutional investors also adjusted their holdings in Acadia Healthcare.
ETFs Investing in Acadia Healthcare Company, Inc. Stocks
This article lists various Exchange Traded Funds (ETFs) that hold stocks of Acadia Healthcare Company, Inc. It provides a detailed table including each ETF's market value, weight of Acadia Healthcare stock, issuer, management style, focus, expense ratio, AUM, price, change percentage, relative volume, and 3-year NAV total return. The information aims to help investors understand how to invest in stocks like Acadia Healthcare through diversified ETFs, offering more opportunities with lower risk.
Why Acadia Healthcare (ACHC) Is Down 17.3% After Raising 2026 Revenue Guidance Amid Earnings Drop
Acadia Healthcare (ACHC) shares dropped 17.3% despite the company raising its 2026 revenue guidance to US$3.40–US$3.45 billion. This follows a second quarter where sales were flat and net income sharply declined to US$10.93 million. The market reaction indicates that ongoing legal and regulatory risks and weak quarterly earnings overshadowed the positive long-term outlook driven by new facility ramp-ups.
Why Acadia Healthcare (ACHC) Is Down 17.3% After Raising 2026 Revenue Guidance Amid Earnings Drop
Acadia Healthcare (ACHC) saw its stock drop despite raising its 2026 revenue guidance, attributed to flat quarterly revenue and a sharp decline in net income. The company's increased full-year outlook relies on new facilities ramping up, while ongoing legal and regulatory issues continue to pressure profitability. Investors are advised to consider these risks alongside the projected long-term demand for behavioral health services and the company's expanding bed base.
Acadia Healthcare Number of Employees 2026 | Employee Count & Headcount Data
Acadia Healthcare (ACHC) had approximately 24,945 employees worldwide as of March 2026, a 1.5% decline from 2023. The company is actively hiring, with 2,511 active job postings in 2026, and its workforce is primarily concentrated in the United States. Employee sentiment is reported as negative and declining, while the average salary is $70,758.
Why Acadia Healthcare (ACHC) Is Down 17.3% After Raising 2026 Revenue Guidance Amid Earnings Drop
Acadia Healthcare (ACHC) experienced a 17.3% drop despite raising its 2026 revenue guidance to US$3.40–US$3.45 billion. This is due to flat quarterly sales, a sharp decline in earnings, and ongoing legal and regulatory risks offsetting the benefits of new facilities ramping up. Investors are weighing the increased full-year outlook against current profit pressures and potential future liabilities.
Acadia Goes Back to Basics, Hones In on Bed Addition Strategy
Acadia Healthcare is focusing on a bed addition strategy to drive growth, having added over 3,000 new beds in the last three years and planning 600 more by the end of 2026. CEO Debra Osteen reported that ramping efforts are exceeding expectations, despite the company experiencing leadership changes, a stock drop, and ongoing legal and financial headwinds. Acadia is also emphasizing expense discipline, strong referral partnerships, and expanding measurement-based care initiatives.
Guggenheim raises Acadia Healthcare stock price target on EBITDA beat
Guggenheim has increased its price target for Acadia Healthcare (NASDAQ:ACHC) shares to $39 from $38, maintaining a Buy rating after the company's Q2 results. Despite an initial 16% stock drop due to investor expectations and increased liability expenses, Acadia's core EBITDA beat forecasts, driven by strong patient volumes. The firm anticipates future significant EBITDA growth from new facility openings and improved free cash flow.
ACHC|Acadia Healthcare Company Inc|Price:27.340|Chg%:-5.350
TradingKey provides a comprehensive stock analysis of Acadia Healthcare Company Inc (ACHC), highlighting its stable fundamentals, significant growth potential, and "fairly valued" status within the Healthcare Providers & Services industry. The report notes high institutional ownership and recent "Buy" ratings from analysts, with a highest price target of $31.86, suggesting a stable stock price in the medium term despite recent market performance. Acadia Healthcare is identified as a provider of behavioral healthcare services operating a network of 262 facilities across 39 states and Puerto Rico, demonstrating strong profit growth but also a recent turnaround to a loss.
Acadia Healthcare (ACHC) Stock Price Sinks As Trailing Loss Clouds Turnaround
Acadia Healthcare (ACHC) stock dropped over 16% due to investor focus on its trailing US$1.1 billion loss, despite reporting a Q2 net income of US$10.9 million. While bulls view it as a turnaround, bears highlight declining net income year-on-year and a reliance on government payers, questioning the sustainability of its quarterly profitability. The significant share price drop suggests investors still see the turnaround as fragile and not yet a sustained earnings recovery.
Acadia Healthcare slides as reserve charge and weak profit trends overshadow Q2 beat
Acadia Healthcare (ACHC) stock dropped 16.3% following its Q2 earnings report, despite beating expectations, due to investor concerns over earnings quality. The profit decline was attributed to increased liability costs and a significant adjustment to reserves, overshadowing an otherwise flat revenue and updated full-year guidance. Several institutional investors have adjusted their positions, and analysts have provided varied price targets for the stock.
Acadia Healthcare Co Inc (ACHC) Q2 2026 Earnings Call Highlights: Strong Financial Management ...
Acadia Healthcare Co Inc (ACHC) reported strong Q2 2026 results, exceeding revenue guidance and achieving solid financial management with $124 million in free cash flow and $113 million debt reduction. Despite flat total revenue and some segment challenges, the company expanded capacity with two new facilities and maintained positive labor market trends. Q&A highlights focused on the successful ramp-up of new beds, disciplined capital allocation, operational improvements, and stability in bad debts and payer denials.
Acadia Healthcare Company, Inc. Stock 12‑Month Price Target Raised to $33.04, Implies 1% Upside
Analysts have raised the 12-month average price target for Acadia Healthcare Company, Inc. (ACHC) stock to $33.04, up from $32.21, with forecasts ranging from $14.5 to $40 per share. Based on the closing price of July 28, this new target suggests a 1% potential upside. The consensus rating for ACHC remains "Buy" among 14 analysts, comprising 8 Buys, 5 Holds, and 1 Sell.
Transcript : Acadia Healthcare Company, Inc., Q2 2026 Earnings Call, Jul 29, 2026
This article provides the transcript for Acadia Healthcare Company, Inc.'s Second Quarter 2026 Earnings Conference Call, held on July 29, 2026. Prior to the call, Acadia Healthcare announced a drop in adjusted earnings and revenue for Q2 2026, despite raising its full-year 2026 guidance, which led to a share price drop after hours. The company reported Q2 revenue of $865.8M and adjusted EPS of $0.38.
Acadia Healthcare Company, Inc. Stock 12‑Month Price Target Raised to $33.04, Implies 1% Upside
The average 12-month price target for Acadia Healthcare Company, Inc. (ACHC) stock has been raised from $32.21 to $33.04 by 14 analysts, implying a 1% potential upside from its July 28 closing price. The consensus rating remains "Buy," with 8 analysts recommending Buy, 5 Hold, and 1 Sell.
Acadia Healthcare Q2 2026 slides: strong cash flow amid flat revenue
Acadia Healthcare (NASDAQ: ACHC) reported flat Q2 2026 revenue of $866 million and a significant 54% drop in adjusted EPS to $0.38, primarily due to a $39 million increase in liability expenses. Despite these challenges, the company demonstrated strong financial discipline, generating $124 million in free cash flow, representing a $158 million improvement year-over-year, and updated its full-year guidance upwards across most metrics. Acadia aims to achieve over $200 million in incremental EBITDA from new facilities as they mature, reflecting a strategic focus on operational efficiency and debt reduction.
Acadia Healthcare Q2 Earnings Call Highlights
Acadia Healthcare (ACHC) reported Q2 2026 results that met expectations, driven by progress in new facilities, spending discipline, and strong free cash flow. While revenue remained flat year-over-year at $866 million, excluding supplemental payments, it would have increased by 2.8%. The company updated its full-year 2026 outlook, forecasting revenue of $3.4 billion to $3.45 billion and adjusted EBITDA of $590 million to $615 million.
Acadia Healthcare Q2 Earnings Call Highlights
Acadia Healthcare reported stable Q2 2026 revenue of $866 million, with growth of 2.8% excluding supplemental payment programs, and an adjusted EBITDA of $149.2 million. The company expanded its network, adding over 300 beds in the first half of 2026, and updated its full-year outlook to $3.4 billion to $3.45 billion in revenue and $590 million to $615 million in adjusted EBITDA. Acadia generated $124 million in free cash flow and repaid $113 million in debt, maintaining a stable labor market and controlled corporate overhead.
Acadia Healthcare Company, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:ACHC)
Acadia Healthcare Company, Inc. (ACHC) has released its Q2 2026 earnings call presentation. The company reported an EPS of $0.38, beating estimates by $0.03, and revenue of $865.84 million, surpassing expectations by $21.62 million despite a slight year-over-year decrease. This presentation provides detailed insights into their financial performance for the quarter.
Acadia Healthcare Q2 Earnings Beat Estimates on Higher Admissions
Acadia Healthcare (ACHC) reported Q2 adjusted earnings of 38 cents per share, surpassing the Zacks Consensus Estimate by 15.2%, despite a 54% year-over-year decline. Revenues also exceeded expectations, driven by higher admissions and improved same-facility patient days. The company provided an updated 2026 outlook, increasing revenue, adjusted EBITDA, adjusted EPS, and operating cash flow forecasts.
Acadia Healthcare Q2 Earnings Beat Estimates on Higher Admissions
Acadia Healthcare (ACHC) reported Q2 earnings of 38 cents per share, surpassing Zacks' estimate by 15.2%, despite a 54% year-over-year decline in earnings. Total revenues of $865.8 million also beat estimates, driven by strong patient demand and increased admissions, particularly in Residential Treatment Facilities. The company updated its 2026 outlook, raising revenue, adjusted EBITDA, and EPS guidance.
Acadia Healthcare Company Inc (ACHC) Financial Health: Profitability & Balance Sheet Analysis
Acadia Healthcare Company Inc (ACHC) has a weak financial status with a current score of 7.93, ranking 31 out of 75 in its industry. The company's latest quarterly revenue decreased by 0.39% year-over-year, and its net profit saw a significant decrease of 63.73%. Despite weak financials, its operating efficiency is noted as high.
Acadia Healthcare (NASDAQ: ACHC) details Q2 2026 profit hit and cash strength
Acadia Healthcare reported a decline in Q2 2026 net income to $10.9 million and diluted EPS of $0.12, primarily due to higher operating costs, a property impairment charge, unfavorable actuarial adjustments, and legal settlement expenses. Despite the profit hit, the company demonstrated strong cash generation, with operating cash flow increasing to $223.6 million for the first half of 2026 and maintaining strong liquidity with $171.3 million in cash and $669.8 million in revolving credit availability. The company is actively addressing ongoing legal proceedings and government investigations, which have contributed to increased costs.
Acadia Healthcare Company, Inc. Stock 12‑Month Price Target Raised to $32.54
Acadia Healthcare Company, Inc. (ACHC) has seen its average 12-month price target raised to $33.04 by 14 analysts, up from $32.21, implying a potential 1% upside from its July 28 closing price. The consensus rating for the stock remains "Buy," with a breakdown of 8 Buys, 5 Holds, and 1 Sell. Investors can find more detailed price target data and analyst recommendations on TradingView's Forecasts tab and News Flow sections.
Acadia Healthcare Q2 2026 Earnings Report
Acadia Healthcare (NASDAQ: ACHC) reported better-than-expected Q2 2026 earnings, with an actual EPS of $0.38 against a consensus of $0.35, and actual revenue of $865.84 million surpassing the expected $844.19 million. The company's Q2 earnings announcement occurred after market close on July 28, 2026, with a conference call scheduled for July 29, 2026, at 9:00 AM ET. Despite the positive earnings beat, other news highlights include ongoing class-action lawsuit information for stockholders and updated full-year 2026 guidance.
Acadia Healthcare Q2 Adjusted Earnings, Revenue Fall; Raises 2026 Guidance; Shares Drop After-Hours
Acadia Healthcare reported a decrease in Q2 adjusted earnings and revenue compared to the prior year. Despite this, the company raised its 2026 guidance, yet its shares still experienced an after-hours drop. This indicates investor apprehension even with a more positive long-term outlook.
